The primary objective of the trial is to determine the maximum tolerated dose (MTD) of Azedra in children with neuroblastoma. Secondary goals are to determine tumor and dose
The alliance includes a license and development agreement relating to DxTech’s proprietary technology, a distribution agreement and an agreement to establish a joint venture between the companies for
Mr Gregory’s resignation will become effective May 31, 2008. In the interim, Mr Gregory will work with Shai Gozani, president and CEO, to transition management of those areas
The Percutaneous Transluminal Angioplasty (PTA) catheter is not labeled for use in the coronary or neuro-vasculature. Thomas Trotter, president and CEO of AngioScore, said: “This latest 510(k) clearance
Concurrently, Eusa has divested its recombinant L-asparaginase therapeutic research program for acute lymphoblastic leukemia to the Alize Pharma Group. EUSA acquired both the antibody business and oncology program
The study was designed to demonstrate the ability of TPM to deliver lidocaine (5%) to a targeted local site after a single topical application, while restricting systemic exposure.
The initial clinical validation study completed at Clarient from prostate tissues obtained in collaboration with MD Anderson Cancer Center demonstrated a very high success rate for identifying the
The protein will be manufactured at QSV’s Edmonton facility and is intended for clinical trials. Work on the project is to begin immediately, and will include technology transfer,
The BD GeneOhm VanR assay is a qualitative in vitro polymerase chain reaction test for the detection of vancomycin-resistant genes directly from perianal and rectal swabs. As the
Osteotech and BioHorizons previously entered into an agreement for BioHorizons to distribute Osteotech’s products to the US dental market in 2000. Sam Owusu-Akyaw, Osteotech’s president and CEO, said:
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.